Clinical trial REGINA
A phase II trial of neoadjuvant REGorafenib in combination with nIvolumab and short-course radiotherapy iN intermediate-risk, stage II-III rectAl cancer
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Institut Jules Bordet |
| EudraCT Identifier | 2020-000876-40 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04503694 |
| Last update |